LY3873862

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3873862, covering 2025-05-11 to 2025-05-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3873862 in Healthy Participants [Phase 1]